Biostatistics Core
生物统计学核心
基本信息
- 批准号:8435576
- 负责人:
- 金额:$ 20.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllograftingAnimalsBiologicalBiostatistics CoreClinical ResearchClinical TrialsClinical Trials DesignConsultDataData AnalysesDevelopmentDrug FormulationsExperimental DesignsGoalsHematological DiseaseInstructionLaboratoriesManuscriptsMarrowMethodologyMethodsModificationPhasePopulationPreparationPrincipal InvestigatorProceduresProgram Research Project GrantsProtocols documentationRandomizedReportingResearchResearch PersonnelResearch Project GrantsRoleSafetySample SizeStatistical Data InterpretationTranslatingWritingbasedesignexperienceleukemiamemberpre-clinicalpreclinical studyprimary outcomeprogramsprotocol developmentresearch study
项目摘要
The Biostatistics Core (Core B) will provide biostatistical expertise in the design, conduct and analysis of the
clinical trials, animal studies and related research projects generated under this proposal. The goals of the
Core are to provide biostatistical support to the six projects at all phases of the research. Core staff will
consult with investigators prior to the initiation of studies to review study objectives and assist in selecting
efficient designs and sample sizes that will provide adequate power to address the objectives. For clinical
studies, a Core member will conduct a protocol review with investigators and assist in protocol development,
sample size determination, plans for interim analyses, and if applicable, randomization. Core staff will
perform statistical analyses and data exploration for POI investigators using appropriate statistical
methodologies; prepare reports of results; assist with the preparation of presentations and writing of
statistical components of manuscripts; and consult on the design of subsequent research. The Core director
has widespread experience in applied and methodologic statistical research, which will allow for the most
appropriate methodologies to be utilized as well as for modification or development of new methods if
needed.
生物统计学核心(核心B)将提供设计、实施和分析
临床试验、动物研究和相关研究项目。的目标
核心是在研究的各个阶段为六个项目提供生物统计支持。核心员工将
在研究开始前咨询研究者,以审查研究目的并协助选择
有效的设计和样本量,将提供足够的权力,以解决这些目标。为临床
研究,核心成员将与研究者一起进行方案审查,并协助方案制定,
样本量确定、中期分析计划以及随机化(如适用)。核心员工将
使用适当的统计数据为POI调查员进行统计分析和数据探索
方法;编写结果报告;协助编写介绍和编写
手稿的统计组成部分;并就后续研究的设计提供咨询。核心导演
在应用和方法学统计研究方面具有广泛的经验,这将允许最
拟采用的适当方法以及用于修改或开发新方法的方法,
needed.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Glenn Heller其他文献
Glenn Heller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Glenn Heller', 18)}}的其他基金
Inferential methods to assess the incremental value of new biomarkers in risk classification models
评估风险分类模型中新生物标志物增量价值的推理方法
- 批准号:
9309399 - 财政年份:2017
- 资助金额:
$ 20.42万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 20.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 20.42万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 20.42万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 20.42万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 20.42万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 20.42万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 20.42万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 20.42万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 20.42万 - 项目类别: